Breaking News

EBP Chair and UC Davis Professor Harris Lewin also said that he and his partners have organized a pilot study in the Amazon basin as a proof-of-concept project.

Premaitha had been sued by Illumina for allegedly infringing on five patents related to noninvasive prenatal testing with its Iona test.

Researchers hope the genomes of the Mexican axolotl and the Schmidtea mediterranea worms will facilitate further studies on the processes behind regeneration. 

A family of tail-less, double-stranded DNA viruses with potent bacteria killing abilities turned up in Vibrionaceae family bacteria from marine samples.

The test has been validated for use with the same full set of female urogenital specimens that are used with Cobas NT/NG testing, as well as for use with male urine. 

The company said it anticipates using net proceeds for working capital and general corporate purposes.

Abbott's CFO said he expects mid-single-digit growth from diagnostics in Q1 2018 and mid-to-high single digit growth for the full year. 

The first available test on the PCR-based Accula platform will be for the diagnosis of influenza A and B virus infection.

The firm also announced the appointment of new board members as it heads toward commercialization of a portable MDx platform.

Biocartis will help develop and commercialize Immunexpress' Septicyte test to run on the Idylla platform.

The new guidelines said ROS1, KRAS, BRAF, MET, RET, and HER2 should be included in targeted and expanded panels.

The US Food and Drug Administration cleared Qiagen's Ipsogen JAK2 RGQ PCR Kit for additional use in the diagnosis of all myeloproliferative neoplasms

The firm plans to integrate its technology with a compatible microfluidic sample prep method developed by researchers at Columbia University.

The six-year, $190 million Somatic Cell Genome Editing program aims to remove barriers that slow the adoption of genome editing for treating patients.

Cornell claims that it was fraudulently induced into settling a patent-infringement lawsuit it filed with Life Tech against Illumina.

Sales of BioFire FilmArray products accounted for more than half of the growth in the quarter.

Driven by strong pharma sales, the company's revenues rose to $687 million from $629 million in Q4 2016, besting the consensus analyst estimate of $669 million.

UgenTec will develop artificially intelligent software to support interpretation of MDxHealth's ConfirMDx and SelectMDx molecular prostate cancer tests.

The funding will support various projects and research centers that are advancing precision medicine and genomic technology development.

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.